**(See the editorial commentary by Klugman et al on pages 321--2.)**

*Streptococcus pneumoniae* is a human-adapted commensal pathogen colonizing the nasopharynx in up to 60% of preschool children \[[@JIT481C1], [@JIT481C2]\]. Even though invasive disease is an unlikely event of infection, this organism is estimated to cause the death of \>800 000 children \<5 years of age worldwide annually \[[@JIT481C3]\]. Epidemiological studies have revealed that pneumococci expressing particular capsular serotypes dominate in invasive pneumococcal disease among children, and it is against such pediatric serotypes that polysaccharide-conjugate vaccines (PCVs) have been directed. Comparisons of the prevalence of carriage and invasive isolates within the same geographical area and period demonstrate that particular serotypes (ie, those with a high invasive-disease potential) are associated with a higher potential than others to cause invasive disease \[[@JIT481C4]--[@JIT481C6]\].

It has been difficult to demonstrate whether different clonal lineages of pneumococci, independent of capsular type, differ in their ability to cause invasive disease. One reason is that many serotypes, including those with a high invasive-disease potential, such as serotypes 1, 4, and 7F, belong to only 1 or a few dominating genetic lineages \[[@JIT481C5], [@JIT481C7], [@JIT481C8]\]. Among serotypes with a low invasive-disease potential, such as serotype 19F, many different genetic lineages are found, but since the number of isolates representing each lineage usually is low the study has to be sufficiently large to demonstrate statistical significance. The same holds true for genetic lineages that may appear with different capsules, such as clonal complex 156 (CC156) \[[@JIT481C9]\].

Because of the highly recombinogenic nature of pneumococci, different isolates belonging to the same genetic lineage, as determined by multilocus sequence typing (MLST), may differ from one another in gene content \[[@JIT481C10], [@JIT481C11]\]. Therefore, even within the same genetic lineage, there may be specific subclones or variants with a higher capacity than others to cause invasive disease. Deletions, insertions, and DNA rearrangements are expected to create differences in pulsed-field gel electrophoresis (PFGE) patterns among isolates belonging to the same genetic lineage as determined by MLST.

In this study, we examined a large set of nasopharyngeal carriage and invasive pneumococcal isolates recovered from children from the Stockholm area during 1997--2004. We calculated the odds ratio (OR) for causing invasive disease and found that different clonal types but also intraclonal variants may exhibit different invasive-disease potentials. Pneumococcal isolates representing intraclonal variants of the most prevalent clonal lineage with different disease outcomes in children were characterized genetically and functionally.

MATERIALS AND METHODS {#s2}
=====================

Clinical Isolates Studied {#s2a}
-------------------------

Nasopharyngeal carriage pneumococcal isolates (n = 550) and invasive pneumococcal isolates (n = 165) were recovered from children (\<18 years of age) during 1997--2004 from the Stockholm area. The mean age was 2.5 years for children with invasive pneumococcal disease and 3.3 years for healthy carriers.

Serotyping {#s2b}
----------

All 715 isolates were serotyped using gel diffusion with 46 serotype/group antisera obtained from Statens Serum Institut in Copenhagen, Denmark \[[@JIT481C2]\].

PFGE Analysis {#s2c}
-------------

All invasive and carriage isolates from children were subjected to PFGE adapted from the procedure described by Hermans et al \[[@JIT481C12]\]. The clones were defined by using the criteria described by Tenover et al \[[@JIT481C13]\].

MLST Analysis {#s2d}
-------------

A total of 200 isolates---165 invasive isolates from children and 35 representatives of clonal types found with PFGE among the carriage isolates---were subjected to MLST analysis. MLST was performed according the procedure described by Enright et al \[[@JIT481C10]\]. The sequences obtained were submitted to the MLST database (available at: <http://www.mlst.net>) and assigned a sequence type (ST). The isolates were assigned to different clonal complexes (CCs), as defined on the basis of the entire collection of isolates within the MLST database \[[@JIT481C14]\], using an algorithm on the MLST Web site from 2008 \[[@JIT481C15]\]. In brief, a CC is defined as a group of STs in a population that shares 6 of 7 alleles with at least 1 other ST in the group. Isolates belonging to a CC may be assumed to have a recent common ancestor \[[@JIT481C15]\]. For isolates without MLST data, we assigned a CC to those that belong to a PFGE clone for which the MLST is available for at least 1 isolate.

Polymerase Chain Reaction (PCR) for *pcpA* and Typing of Prophage DNA {#s2e}
---------------------------------------------------------------------

PCR was performed as previously described \[[@JIT481C9]\]. The presence of *pcpA* was determined using specific primers from the coding region ([Supplementary Table 1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jit481/-/DC1)). The presence of phage genes and individual phage typing was determined as described by Romero et al \[[@JIT481C16]\].

Lysogenic Bacteriophage Induction by Use of Mitomycin C {#s2f}
-------------------------------------------------------

The protocol was adapted from the report by Romero et al \[[@JIT481C16]\]. In brief, *S. pneumoniae* isolates were grown in C + Y medium at 37°C until the culture reached an optical density (OD) at 620 nm of 0.2. Mitomycin C was added to a final concentration of 100 ng/mL to induce release of temperate bacteriophages. Growth was monitored in microtiter plates (5 replicate wells/isolate) with Bioscreen equipment (Labsystems, Finland). Measurements were made at OD~600~ every fifth minute for 16 hours.

Sequencing of *pspC* and *pspA* {#s2g}
-------------------------------

Sequencing of *pspC1* was performed for 4 serotype 6B isolates, and sequencing of *pspC2* and *pspA* was performed for 14 and 12 serotype 6B isolates, respectively, as described previously \[[@JIT481C17], [@JIT481C18]\].

Whole-Genome Shotgun Sequencing {#s2h}
-------------------------------

Whole-genome shotgun sequencing was performed on 4 serotype 6B isolates (BHN237, BHN427, BHN418, and BHN191). Chromosomal DNA was prepared using a Qiagen DNA prep kit (Genomic DNA Buffer Set and Genomic-tip 100/G). The DNA was subjected to sequencing using a Roche Genome Sequencer FLX (GS FLX). Assembly of the 454 data was performed using Newbler v 2.3 \[[@JIT481C19]\]. Genes were predicted using GeneMark.hmm prokaryotic, version 2.6p \[[@JIT481C20]\]. To align the contigs to the reference genome, MUMmer \[[@JIT481C21]\] was used; to visualize the data, Artemis Comparison Tool was used \[[@JIT481C22]\]. Results of this whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under accession number ASHQ00000000.

Factor H (FH) Binding by Use of Far Western Blot and Enzyme-Linked Immunosorbent Assay (ELISA) Analyses {#s2i}
-------------------------------------------------------------------------------------------------------

Strains were grown in C + Y medium to an optical density at 620 nm of 0.6 and harvested by centrifugation. Bacterial pellets were lysed by boiling in 1 × Nupage sodium dodecyl sulfate (SDS) loading solution (Invitrogen). The samples containing 15 µg of proteins from whole-cell lysate of pneumococci (quantified by Bradford Reagent, Sigma-Aldrich) were separated by SDS polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane. The membrane was incubated with 1 µg/mL human FH, followed by incubation with goat anti-FH antibody (1:2000 dilution; Calbiochem) and with rabbit anti-goat immunoglobulin G conjugated with horseradish peroxidase (HRP; 1:8000 dilution; Invitrogen). Detection was performed using the ECL prime Western blotting detection reagent (GE Healthcare) and developed using Gel-doc (Biorad).

FH binding was also quantified using whole-cell ELISA. Microtiter plates were coated overnight with 5 µg/mL FH at 4°C. Subsequent steps were conducted at room temperature for 2 hours each. After washes with 0.05% Tween 20 in phosphate-buffered saline (PBS), nonspecific binding sites were blocked with 1% skim milk in PBS and washed again, and 2 × 10^6^ bacteria were added. Bound bacteria were detected using a 6B specific polyclonal anticapsule (Statens Serum Institut, Denmark) diluted 1:1000 in 0.1% BS and anti-rabbit-HRP. SigmaFast OPD (Sigma) was used for detection, and absorbance was measured at 492 nm. Three different experiments were done in triplicate.

Animal Model {#s2j}
------------

C57BL/6 mice were infected intranasally with 5 × 10^6^ colony-forming units (CFU). Blood samples were collected every 24 hours, and the bacterial load in lungs was determined at the time of euthanization. The experiments were approved by the local ethics committee (Stockholms Norra djurförsöksetiska nämnd).

Statistical Analysis {#s2k}
--------------------

ORs were calculated to estimate the potential of causing invasive disease for different serotypes and clonal types, as follows: OR = \[*ad*\]/\[*bc*\], where *a* the number of invasive clone X isolates, *b* is the number of carriage clone X isolates, *c* is the number of invasive clone non-X isolates, and *d* the number of carriage clone non-X isolates. ORs and 95% confidence intervals (CIs) were calculated using the Fisher method implemented in the Epitools package for statistical software R, version 2.13.0 (available at: <http://www.r-project.org>). An OR of \>1, along with a 95% CI that did not include 1, indicated an increased risk for causing invasive disease.

The data from animal experiments were analyzed using GraphPad Prism 4 software. Survival curves were analyzed using the log-rank test, and blood CFU data were analyzed using the Kruskal-Wallis test.

RESULTS AND DISCUSSION {#s3}
======================

All 715 invasive and carriage isolates were subjected to serotyping and molecular typing to study genetic relatedness, using PFGE and/or MLST (Table [1](#JIT481TB1){ref-type="table"}). The nomenclature for PFGE variants indicates a particular pattern within the dominating serotype, whereas the MLST data allow grouping of isolates into different CCs. The ORs for invasive disease were calculated for each PFGE pattern and are given in Table [1](#JIT481TB1){ref-type="table"}. Isolates belonging to CCs associated with the highest invasive-disease potential (CC306, CC205, and CC191) were represented by isolates belonging to mainly 1 serotype (types 1, 4, and 7F, respectively). Table 1.Odds Ratio (OR) of Clonal Types Determined Using Pulsed-Field Gel Electrophoresis (PFGE)Isolates, No.PFGE cloneTotalInvasiveCarriageOther serotypesCC^a^OR (95% CI)CommentSWE14-6^b^770-15∞ (4.94-∞)All invasiveSWE11A-113310-621.00 (0.17-3.95)SWE19F-5808-630.00 (0.00-1.95)All carriageSWE18C-11721510A,6A, 18B1130.44 (0.05-1.91)SWE18C-3^b^6516B113**17.07** (1.89-809.23)SWE14-214311-1240.91 (0.16-3.49)SWE14-3^b^853-124**5.68** (1.09-36.97)SWE14-4624-1241.67 (0.15-11.8)SWE23F-22141719A, 19F, 35F1240.78 (0.19-2.44)SWE6B-16116456A1381.20 (0.62 -2.25)SWE6B-234925-1381.21 (0.49-2.75)SWE6B-3^b^7616A138**20.62** (2.47-949.68)SWE14-1233209V,19F1560.49 (0.09-1.69)SWE3-112210-1800.66 (0.07-3.16)SWE7F-1^b^18126-191**7.09** (2.41-23.4)SWE14-550519A1990.00 (0.00-3.64)All carriageSWE19A-12561919F, 15B, 15C1991.05 (0.34-2.81)SWE4-16426A2056.78 (0.96-75.51)SWE19F-6505-2710.00 (0.00-3.64)All carriageSWE19F-7505-2710.00 (0.00-3.64)All carriageSWE1-1^b^14131-306**46.68** (6.91-1977.78)SWE19F-411011-3090.00 (0.00-1.32)All carriageSWE38-1606-3930.00 (0.00-2.83)All carriageSWE16F-116214-4140.47 (0.05-2.08)SWE19F-2716-4250.55 (0.01-4.61)SWE23F-12942519A4390.52 (0.13-1.54)SWE23F-3505-4390.00 (0.00-3.64)All carriageSWE6A-414212-4600.55 (0.06-2.51)SWE6A-9808-4600.00 (0.00-1.95)All carriageSWE6A-8505-4730.00 (0.00-3.64)All carriageSWE6A-122418-4900.73 (0.18-2.27)SWE6B-4505-5530.00 (0.00-3.64)All carriageSWE19A-2^b^752-NPF**8.53** (1.38-90.45)SWE19F-1909-NPF0.00 (0.00-1.68)All carriageSWE19F-9808-NPF0.00 (0.00-1.95)All carriageSWE35B-111011-NPF0.00 (0.00-1.32)All carriageSWE35F-1606-NPF0.00 (0.00-2.83)All invasiveSWE6A-2505-NC0.00 (0.00-3.64)All carriageSWE19F-3505-NC0.00 (0.00-3.64)All carriageSWE19F-8505-NC0.00 (0.00-3.64)All carriageNT505-NC0.00 (0.00-3.64)All carriageOther^c^211451660.87 (0.57-1.30)**Total**715165550[^2][^3][^4][^5][^6]

The results presented in Table [1](#JIT481TB1){ref-type="table"} suggest that isolates with different PFGE patterns and/or different CCs differ in their OR for causing invasive disease. Thus, isolates of PFGE SWE14-6 belonging to CC15 (all serotype 14) had a higher invasive-disease potential than serotype 14 isolates of CC124 (PFGE SWE23F-2, SWE14-2, SWE14-3, and SWE14-4) and CC156 (39% of serotype 14; Table [1](#JIT481TB1){ref-type="table"}). For serotype 19F, a multitude of different PFGE types and CCs were found, and the 3 isolates of PFGE pattern SWE19F-10 (CC251; data not shown) were solely from individuals with invasive disease. The other PFGE clones of serotype 19F belonged to different CCs and were almost exclusively found among healthy carriers (Table [1](#JIT481TB1){ref-type="table"}). These findings suggest that the invasive-disease potential for a serotype can be affected by its clonal distribution within that serotype.

Of particular interest was the presence of different PFGE patterns with different invasive-disease potentials belonging to the same genetic lineage (CC) and serotype, as exemplified for CC138 (type 6B), CC124 (type 14), and CC113 (type 18C; Table [1](#JIT481TB1){ref-type="table"}).

Comparative Genomics on CC138 Isolates Reveal Important Differences That May Influence Disease Outcome {#s3a}
------------------------------------------------------------------------------------------------------

CC138 was the most common genetic lineage among children with invasive disease and healthy carriers; this CC was observed in 110 isolates, of which 107 were of serotype 6B. One subclone, SWE6B-3 by PFGE, belonging to CC138 showed a high OR for causing invasive disease, in contrast to 2 other CC138 subclones, SWE6B-1 and SWE6B-2 (Table [1](#JIT481TB1){ref-type="table"}). Four serotype 6B isolates representing these 3 PFGE patterns with different invasive-disease potentials were selected for whole-genome sequencing (Figure [1](#JIT481F1){ref-type="fig"}*A* and [1](#JIT481F1){ref-type="fig"}B and Tables [1](#JIT481TB1){ref-type="table"} and [2](#JIT481F2){ref-type="fig"}). The invasive isolate BHN191 represented SWE6B-3, strongly associated with invasive disease, while carriage isolate BHN418 came from the less invasive SWE6B-2. SWE6B-1 was represented by BHN237 from an individual with invasive disease and by BHN427 from a healthy carrier. Figure 1.Genomic differences between (A) invasive BHN191 from SWEB-3 and carriage BHN418 from SWEB-2 and (B) between invasive BHN237 and carriage BHN427, both from SWE6B-1. Figure 2.Factor H binding to the 4 strains of 6B and clonal complex 138, using Far Western blotting.

### Intraclonal Variations in the Presence, Location, and Function of Prophages {#s3a1}

The pneumococcal genome contains a large number of accessory regions (ARs), defined as at least 3 consecutive genes only present in a subset of clinical isolates \[[@JIT481C7]\]. The 4 CC138 isolates contained roughly the same ARs. The 2 exceptions were AR13, encoding a putative type 1 restriction system, which was missing in BHN237 and BHN427, and AR29, encoding a putative ABC transporter in which about two thirds of the genes were present in BHN237 and BHN427 but missing in the other isolates. Our previous identification of ARs \[[@JIT481C7]\] was based on the TIGR4 and R6 genomes, both of which lack prophages. However, pneumococcal prophages are common \[[@JIT481C16]\] and represent large segments of integrated DNA that might affect PFGE patterns in otherwise genetically related strains. Analyses of the 4 genomes revealed that 3 of the 4 CC138 isolates carried clustered genes homologous to identified prophage genes of pneumococci and commensal streptococci. Only carrier isolate BHN418 of SWE6B-2 lacked integrated prophage DNA (Figure [1](#JIT481F1){ref-type="fig"}A and [1](#JIT481F1){ref-type="fig"}B; data not shown). Phages of group 3 were present in the 2 invasive isolates BHN191 and BHN237, each located between the genes homologous to the TIGR4 genes SP_0020 and SP_0021. These 2 group 3 phages were very similar in the 2 invasive isolates, with an overall nucleotide sequence identity of 92% (counted over aligned sequences but not including sequence areas between contigs where sequence information is lacking). The sequence identity varied over the phage genome and over areas covering 89% of the phage sequence, and the nucleotide identity was 97%. Phages of group 2 were found in the 2 isolates of SWE6B-2 (BHN237 and BHN427) and were also similar but not identical in the 2 genomes (82% nucleotide sequence identity over alignable areas). BHN191 belonging to SWE6B-3 contained a second prophage that did not correlate with any of the 3 phage groups described by Romero et al \[[@JIT481C16]\], but similar sequences can be found in the 2 sequenced isolates SP19-BS75 and JJA (GenBank accession numbers ABAF00000000 and CP000919). In both BHN191 and JJA, the phage is located between TIGR4 genes SP_1908 and SP_1909.

To further investigate the possible role of the prophages in intraclonal variation and invasive-disease potential, we next studied the presence of phages in all serotype 6B isolates by PCR and performed functional assays of lysogeny by phage induction using mitomycin C \[[@JIT481C16]\] (Table [2](#JIT481TB2){ref-type="table"}). All isolates belonging to SWE6B-3 (all but 1 were invasive isolates) and 58 of 61 isolates belonging to SWE6B-1 (invasive and carrier isolates) were shown to harbor at least 1 phage type, with phage group 3 being the most prominent, whereas prophages were absent in most (25 of 34) isolates belonging to SWE6B-2 (the majority of which were carrier isolates). Isolates that had a lysogenic phage (Table [2](#JIT481TB2){ref-type="table"}) were also positive by PCR. However, we found lysogenic isolates that did not fully react with any of the 3 phage group--specific PCR primers, suggesting that there are additional phage groups present. Also, some isolates reacted positively with use of phage-specific primers, even though no phage induction was seen with mitomycin C, suggesting the presence of incomplete prophages. For SWE6B-2, we noted that 4 of the 6 isolates harboring inducible phages were invasive isolates, but we found no correlation as such between the presence of phage DNA and either carriage or invasive disease (Table [2](#JIT481TB2){ref-type="table"}). Table 2.Characteristics of All Isolates Belonging to Serotype 6BBHNSerotypePFGESTCC^a^Invasive or CarriagePhage Group(s)^b^Mitomycin C--Induced Lysis*pcpA*^c^*pspA*^d^*pspC1*^e^*pspC2*^e^BHN 191^f^6BSWE6B-3138138I3++Fam2, clade 3PspC6.9PspC9.4BHN 3286BSWE6B-3138138I3++Fam2......BHN 3876ASWE6B-3138138I1, 3++Fam2......BHN 2386BSWE6B-3138138I3++Fam2, clade 3...PspC9.4BHN 2496BSWE6B-3138138I3++Fam2......BHN 2506BSWE6B-3138138I3++Fam2, clade 3...PspC9.4BHN 4606BSWE6B-3138138CUnclassified++Fam2, clade 3......BHN 2736BSWE6B-2176138IUnclassified+−Fam1......BHN 2126BSWE6B-2138138I3−+Fam2, clade 3...PspC9.4BHN 2596BSWE6B-2138138I2++Fam2......BHN 3056BSWE6B-2138138I−−+Fam2...PspC9.4BHN 3106BSWE6B-2138138I3++Fam2......BHN 2176BSWE6B-2138138IUnclassified++Fam2......BHN 3796BSWE6B-2138138I3−+Fam2......BHN 3816BSWE6B-2138138I−−+Fam2......BHN 3866BSWE6B-2138138I3−+Fam2......BHN 4616BSWE6B-2138138CRemnant−+Fam2......BHN 4626BSWE6B-2138138C−−+Fam2......BHN 4636BSWE6B-2138138C−−+Fam2......BHN 418^f^6BSWE6B-2138138C−−+Fam1, clade 1PspC6.9PspC9.4BHN 4646BSWE6B-2138138C−−+Fam2......BHN 4656BSWE6B-2138138C−−+Fam2......BHN 4666BSWE6B-2138138C−−+Fam2......BHN 4676BSWE6B-2138138CRemnant−−Fam2......BHN 4686BSWE6B-2138138CRemnant−−Fam2......BHN 4696BSWE6B-2138138C−−+Fam2......BHN 4706BSWE6B-2138138C−−+Fam2......BHN 4716BSWE6B-2138138C−−−Fam2......BHN 5106BSWE6B-2138138C−−+Fam2, clade 3...PspC9.4BHN 506BSWE6B-2176138C−−+Fam2......BHN 4726BSWE6B-2176138CRemnant−+Fam1......BHN 4736BSWE6B-2176138CRemnant−+Fam2......BHN 5436BSWE6B-2138138C−−+Fam1......BHN 5446BSWE6B-2138138C−−+Fam2......BHN 5456BSWE6B-2138138CRemnant−+Fam2......BHN 5466BSWE6B-2138138C3++Fam1......BHN 5476BSWE6B-2138138C−−+Fam2......BHN 5486BSWE6B-2138138C−−+Fam2......BHN 5496BSWE6B-2138138C−−+Fam2......BHN 5506BSWE6B-2138138CUnclassified++Fam2......BHN 4746BSWE6B-2176138CRemnant−+Fam2......BHN 237^f^6BSWE6B-1176138I2, 3++Fam1, clade2PspC6.1PspC9.1BHN 3146BSWE6B-1176138I1, 3++Fam1......BHN 3826BSWE6B-1176138I3−+.........BHN 2006BSWE6B-1176138I−−−Fam2, clade 5...PspC9.1BHN 3226BSWE6B-1176138IUnclassified++Fam1......BHN 2646BSWE6B-1176138I3++Fam1......BHN 2696BSWE6B-1176138I3++Fam1......BHN 2876BSWE6B-1176138I1++Fam1......BHN 3076BSWE6B-1176138I1++Fam1......BHN 2966BSWE6B-1176138I3++Fam1...PspC9.1BHN 3336BSWE6B-1176138I1, 3++Fam1......BHN 2486BSWE6B-1176138I1, 3++Fam1......BHN 2536BSWE6B-1176138I1, 3++Fam1......BHN 3006BSWE6B-1176138I3++Fam1......BHN 2666BSWE6B-1171138I3−+Fam1......BHN 2716BSWE6B-1138138IUnclassified++Fam1......BHN 427^f^6BSWE6B-1176138C2+−Fam1, clade2PspC6.1PspC9.1BHN 4756BSWE6B-1176138C1++Fam1......BHN 4766BSWE6B-1176138C1++Fam1......BHN 4776BSWE6B-1176138C1++Fam1......BHN 5256ASWE6B-1176138C1++Fam1......BHN 4786BSWE6B-1176138C1, 2, 3++Fam1......BHN 4796BSWE6B-1176138C1, 3++Fam1......BHN 4806BSWE6B-1176138CUnclassified+−Fam1...PspC9.1BHN 4816BSWE6B-1176138C2+−Fam1......BHN 4826BSWE6B-1176138C2+−Fam1......BHN 4836BSWE6B-1176138C1++Fam1......BHN 4846BSWE6B-1176138C1, 3+−Fam1......BHN 4856BSWE6B-1176138C1, 3+−Fam1...PspC9.1BHN 4866BSWE6B-1176138C3++Fam1......BHN 4876BSWE6B-1176138C3++Fam1......BHN 4886BSWE6B-1176138C3++Fam1......BHN 4896BSWE6B-1176138C3++Fam1......BHN 4906BSWE6B-1176138C3++Fam1......BHN 4916BSWE6B-1176138C3++Fam1...PspC9.1BHN 4926BSWE6B-1176138C3++Fam1......BHN 4936BSWE6B-1176138C3++Fam1......BHN 4946BSWE6B-1176138C3++Fam1......BHN 4956BSWE6B-1176138C3++Fam1......BHN 4966BSWE6B-1176138C3++Fam1......BHN 4976BSWE6B-1176138C3++Fam1......BHN 4986BSWE6B-1176138C3++Fam1......BHN 4996BSWE6B-1176138C3++Fam1......BHN 5006BSWE6B-1176138C3++Fam1......BHN 5016BSWE6B-1176138C3++Fam1......BHN 5026BSWE6B-1176138CRemnant−+Fam1......BHN 5036BSWE6B-1176138C3++Fam1......BHN 5046BSWE6B-15362C3++Fam1......BHN 516BSWE6B-1176138C3++Fam1......BHN 5056BSWE6B-1176138C3++Fam1......BHN 5266BSWE6B-1176138C2+−Fam1......BHN 5286BSWE6B-1176138CUnclassified++Fam1......BHN 5296BSWE6B-1176138C3++Fam1......BHN 5306BSWE6B-1176138C−++Fam1......BHN 5316BSWE6B-1176138C3++Fam1......BHN 5326BSWE6B-1176138C3++Fam1......BHN 5336BSWE6B-1176138C2++Fam2, clade 3......BHN 5346BSWE6B-1176138C3++.........BHN 5356BSWE6B-1176138C3++Fam1......BHN 5366BSWE6B-1176138C3++Fam1......BHN 5066BSWE6B-1176138C3++Fam1......BHN 5536BSWE6B-4553553CUnclassified++Fam2......BHN 5546BSWE6B-4553553CUnclassified++Fam2......BHN 5556BSWE6B-4553553C2++Fam2......BHN 5566BSWE6B-4553553C2++Fam2......BHN 5576BSWE6B-4553553C1, 3++Fam2......BHN 5596BSWE6B-5553553C1, 3++Fam2......BHN 5606BSWE6B-5553553C1++Fam2......BHN 3206BSWE6B-638590IUnclassified++Fam1......BHN 3046BSWE6B-7315315IUnclassified++Fam2......BHN 3026BSWE6B-7315315I−−+Fam2......BHN 2726BSWE6B-8265990IUnclassified++Fam1......BHN 2556BSWE6B-814690IUnclassified++Fam1......BHN 3066BSWE6B-926602660IUnclassified++Fam1......BHN 2786BSWE6B-109090I1, 2++Fam1......BHN 1976BSWE6B-11138138I2++Fam2......BHN 5076BSWE6B-12176138C2, 3++Fam1......BHN 5146BSWE6B-13176138CUnclassified++Fam1......BHN 5156BSWE6B-148790Not present in any groupC−−+Fam1......BHN 5166BSWE6B-152156156CUnclassified++Fam1......BHN 5176BSWE6B-168789Not present in any groupC−−−Fam1......BHN 5186BSWE6B-178791Not present in any groupC2++Fam1......BHN 5196BSWE6B-18553553C2++Fam2......BHN 5206BSWE6B-19NCNCCUnclassified+−.........BHN 5216BSWE6B-207101121CUnclassified++Fam2......BHN 5226BSWE6B-212936SingletonC−−+Fam1......BHN 5236BSWE6B-22176138CUnclassified++Fam1......BHN 5096BSWE6B-23176138C2, 3−+Fam1......BHN 5086B18C-3138138C3++Fam2......[^7][^8][^9][^10][^11][^12][^13]

### Intraclonal Allelic Variations of Known Virulence Surface Proteins {#s3a2}

The comparative sequence analyses revealed differences among the 4 CC138 isolates in genes encoding the important virulence-associated surface proteins pneumococcal surface protein A (PspA), pneumococcal choline-binding protein A (PcpA), and pneumococcal surface protein C (PspC). These surface proteins are known to represent dominating antigens to which many individuals without prior invasive disease have antibodies \[[@JIT481C23]\].

*pspA* is a mosaic gene that has evolved through extensive recombination and is an important vaccine candidate \[[@JIT481C18], [@JIT481C24]\]. PspA is required for pneumococcal virulence and contributes to colonization in mice, and it has been shown to interfere with the fixation of complement C3 \[[@JIT481C25], [@JIT481C26]\] and to bind human lactoferrin \[[@JIT481C27]\]. PspA can be divided into 3 families and 6 clades, in which the clade-defining region is determined by residues 192--290. It has previously been reported that a single clone usually consists of strains from 1 specific clade. However, in this study of CC138 isolates, we observed extensive intraclonal *pspA* variation (Table [2](#JIT481TB2){ref-type="table"}). Thus, BHN191 of SWE6B-3 possessed a *pspA* allele similar to TIGR4 (*pspA* family 2, clade 3), whereas the other 3 isolates carried a *pspA* allele similar to R6 (*pspA* family 1) but still with sequence differences placing them in different clades (Table [2](#JIT481TB2){ref-type="table"}).

All CC138 6B isolates were subsequently tested for the *pspA* family by use of family-specific primers, and the complete *pspA* gene was sequenced from a selected number of isolates to determine the clade (Table [2](#JIT481TB2){ref-type="table"} and [Supplementary Figures 1 and 2](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jit481/-/DC1)). All isolates from SWE6B-3 belonged to *pspA* family 2, and those sequenced were of clade 3. In SWE6B-2, only a minority of isolates possessed a *pspA* allele of family 1 (clade 1), whereas the majority were of *pspA* family 2 (clade 3). Finally, for SWE6B-1, most isolates carried *pspA* of family 1 (clade 2), but 2 were of family 2 (clades 2 and 5). Thus, for the largest single clone among children (CC138) in Stockholm, we identified extensive *pspA* variation. However, no specific *pspA* family and clade correlated to either carriage or disease.

Another sequence difference among the 4 completely sequenced CC138 strains was the complete absence of *pcpA* in the carrier isolates BHN427 of SWE6B-1 but the presence of this virulence-associated gene in the other 3 isolates (Table [2](#JIT481TB2){ref-type="table"}). In BHN427 *pcpA* was replaced by 2 open reading frames with no similarities to *pcpA* (data not shown). The presence of *pcpA* was further analyzed by PCR in all CC138 isolates (Table [2](#JIT481TB2){ref-type="table"}). The *pcpA* gene was absent in 10 of 72 tested isolates, of which 8 were from healthy carriers and 2 from individuals with invasive disease. PcpA is a potential vaccine candidate, but unlike PspA expression of this protein is not required for colonization in mice \[[@JIT481C28]\].

Each of the 4 CC138 isolates possessed 2 different *pspC* genes, *pspC1,* encoding a choline binding version of this highly variable protein, and *pspC2,* encoding a cell-wall-anchored LPXTG protein. Of the 4 completely sequenced CC138 isolates, BHN191 and BHN418 were of *pspC1* variant PspC6.9. \[[@JIT481C29]\]. Nevertheless, the 2 predicted amino acid sequences differed at a number of locations ([Supplementary Figure 1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jit481/-/DC1); the 2 sequences can be aligned with 80.9% sequence identity, with 4.0% gaps). The 2 *pspC1* genes of BHN237 and BHN427 (both of SWE 6B-1) were, however, identical and of PspC6.1 \[[@JIT481C29]\]. All 4 *pspC1* sequences contain 2 copies of an RNYPT motif known to bind human FH \[[@JIT481C29]\].

The 4 *pspC2* sequences were all very similar but not identical. BHN191 and BHN418 both had a *pspC2* allele of PspC9.4, and the sequences were identical except for the length of the proline-rich repeat region. BHN237 and BHN427, on the other hand, were of PspC9.1 and were 99.1% identical to each other, with all differences in the repeat region. When additional CC138 isolates were sequenced for *pspC2* (Table [2](#JIT481TB2){ref-type="table"}), all SWE6B-3 and SWE6B-2 isolates had a PspC9.4 allele, and the SWE6B-1 isolates were all PspC9.1. The major difference again involved the number of repeats in the proline-rich region.

Intraclonal Variations Within PspC1 and PspC2 and Correlation to Human FH Binding {#s3b}
---------------------------------------------------------------------------------

One human-specific virulence property in pneumococci is the ability to sequester human alternative pathway inhibitor FH, leading to evasion of complement-mediated opsonization. In pneumococci, only PspC1 and PspC2 (Hic) have been shown to bind FH \[[@JIT481C30], [@JIT481C31]\]. Since we could identify sequence variations in the different *pspC1* and *pspC2* genes of the 4 6B CC138 strains, we examined FH binding by use of Far Western blotting (Figure [2](#JIT481F2){ref-type="fig"}). FH was shown to bind 1 major protein in strainT4, corresponding in size (95 kDa) to PspC1 purified from this strain (data not shown). All 4 6B strains were shown to preferentially bind FH to a similarly sized protein as in strain T4, suggesting that it represents PspC1. Interestingly, we found that FH bound more intensively to this protein in invasive strain BHN191, compared with the other 3 strains. Since none of the 4 CC138 strains were possible to transform, we were unable to create mutants in the *pspC1* or *pspC2* genes. FH binding was further quantified by whole-cell ELISA, using strain T4 as the reference strain, in which pneumococci were attached to a microtiter plate and the binding of FH was analyzed. The 4 6B strains were found to sequester more FH than strain T4 (difference, 2--4-fold), with BHN191 exhibiting the highest degree of binding (data not shown), suggesting that enhanced complement resistance could be one explanation why this strain exhibited a higher invasiveness in children than the other isolates. All 4 strains bound FH with maintained cofactor activity, as representative C3b cleavage products were found when the strains were pretreated with FH and incubated with C3b and factor I (data not shown).

Differences in Virulence Within CC138 in an Experimental Mouse Model May Correlate With the Presence of Virulence Protein PcpA {#s3c}
------------------------------------------------------------------------------------------------------------------------------

The 4 CC138 isolates were next tested for virulence in an intranasal murine model. The carrier isolate BHN427 was considerably less virulent than the corresponding invasive isolate BHN237 (Figure [3](#JIT481F3){ref-type="fig"}*A*--*C*). It is likely that this difference in mice virulence reflects the lack of PcpA, a known mouse virulence determinant, in the carrier isolate. However, we found no difference in mouse virulence between invasive BHN191 of SWE6B-3 with high invasive-disease potential, compared with carrier BHN418 of SWE 6B-2 and invasive BHN237 of SWE6B-1, suggesting that the high invasive-disease potential of SWE6B-3 in children may represent 1 or more virulence attributes only operating in the human setting, such as sequestration of human FH. Figure 3.Survival of mice (*A*) and the number of colony-forming units (CFU) in the bloodstream at 24 hours (*B*) after intranasal challenge with the 4 strains of serotype 6B and clonal complex 138 representing clonal types with pulsed-field gel electrophoresis patterns indicating different invasive-disease potentials. \**P* \< .05.

Concluding Remarks {#s3d}
------------------

We found that efficient horizontal gene transfer events generate intraclonal variants in dominating lineages that differ in invasive-disease potential in children and in virulence in mice. Also, we observed major differences in phage DNA content and in the presence or sequence of surface antigens. These surface antigens are known to be important virulence factors, and some bind human FH, which has been shown to increase complement resistance and to promote invasion directly \[[@JIT481C29], [@JIT481C32], [@JIT481C33]\]. We found differential FH binding among intraclonal variants, potentially affecting invasiveness. We hypothesize that a constantly ongoing selection for immune escape variants of pneumococci occurs during carriage that result in variants that may affect the invasive-disease potential in children by simultaneously affecting the disease-promoting properties of individual proteins.

Supplementary Data {#s4}
==================

[Supplementary materials](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jit481/-/DC1) are available at *The Journal of Infectious Diseases* online (<http://jid.oxfordjournals.org/>). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.
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[^1]: Present affiliation: European Centre for Disease Prevention and Control, Stockholm, Sweden.

[^2]: PFGE clones representing ≥5 isolates are shown. A PFGE clone was given its name according to the most prominent serotype in the clone.

[^3]: Abbreviations: CC, clonal complex; NC, nonconclusive; NPF, no predicted founder.

[^4]: ^a^ CCs are named after the predicted founder as of the 2008 Mars Project in the MLST database.

[^5]: ^b^ Significantly associated with invasive disease.

[^6]: ^c^ PFGE clones with \<5 isolates belonging to serotype 6A, 19F, 6B, 23F, 14, 10A, 9 V, 18C, 35F, NT, 3, 21, 11A, 23A, 9N, 15B, 7F, 19A, 33F, 16F, 23B, 4, 8, 31, 38, 11B, 15C, 17F, 22F, and 24F, in decreasing order.

[^7]: Abbreviations: CC, clonal complex; NC, nonconclusive; PCR, polymerase chain reaction; PFGE, pulsed-field gel electrophoresis; ST, sequence type; --, negative; +, positive.

[^8]: ^a^ CCs are named after the predicted founder as of the 2008 Mars Project in the MLST database.

[^9]: ^b^ Defined by a positive PCR product of primer pairs designed by Romero et al \[[@JIT481C16]\]. The term "unclassified" denotes a lysogenic strain but no detectable PCR product, suggesting the presents of a novel prophage not belonging to any of the 3 groups previously described by Romero et al \[[@JIT481C16]\]. The term "remnant" denotes expression of genes without lyse upon induction of mitomycin C.

[^10]: ^c^ Determined by PCR, using specific primers.

[^11]: ^d^ Determined by PCR, using specific primers, and clades by sequencing.

[^12]: ^e^ Determined by Sanger sequencing. For *pspC1*, PspC6.9 was from G386, and PspC6.1 was from G31. For *pspC2,* PspC9.4 was from G386, and PspC9.1 was from G31.

[^13]: ^f^ Selected for whole-genome sequencing.
